{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:41:22Z","timestamp":1760661682125,"version":"build-2065373602"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ajpc.2025.101070","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T15:05:45Z","timestamp":1753542345000},"page":"101070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Demystifying the nuances of the lipid patient: a guide for primary care providers"],"prefix":"10.1016","volume":"23","author":[{"given":"Merle","family":"Myerson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle","family":"Gillett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"O\u2019Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Potter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Skolnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpc.2025.101070_bib0001","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35025203","article-title":"Atherosclerosis","volume":"407","author":"Lusis","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ajpc.2025.101070_bib0002","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.jacc.2022.07.006","article-title":"2022 ACC expert consensus decision pathway on the role of nonstatin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American College of Cardiology solution set oversight committee","volume":"80","author":"Lloyd-Jones","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2025.101070_bib0003","first-page":"250","article-title":"Pathobiological determinants of atherosclerosis in youth (PBDAY Study), 1986-96","volume":"77","author":"Sternby","year":"1999","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.ajpc.2025.101070_bib0004","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101070_bib0005","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2025.101070_bib0006","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.15420\/ecr.2019.18","article-title":"Assessing atherosclerotic cardiovascular disease risk with advanced lipid testing: state of the science","volume":"15","author":"German","year":"2020","journal-title":"Eur Cardiol"},{"key":"10.1016\/j.ajpc.2025.101070_bib0007","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009251","article-title":"Measurement of low-density lipoprotein cholesterol levels in primary and secondary prevention patients: insights from the PALM registry","volume":"7","author":"Lowenstern","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ajpc.2025.101070_bib0008","doi-asserted-by":"crossref","first-page":"E87","DOI":"10.1093\/eurheartj\/suaa068","article-title":"Subclinical atherosclerosis: how and when to treat it?","volume":"22","author":"Gatto","year":"2020","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.ajpc.2025.101070_bib0009","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","article-title":"2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101070_bib0010","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jacc.2018.06.046","article-title":"Impact of lipids on cardiovascular health: JACC health promotion series","volume":"72","author":"Ference","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2025.101070_bib0011","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1161\/CIRCULATIONAHA.106.676890","article-title":"Subendothelial lipoprotein retention as the initiating process in atherosclerosis","volume":"116","author":"Tabas","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101070_bib0012","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2025.101070_bib0013","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.4158\/CS-2020-0490","article-title":"Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the management of dyslipidemia and prevention of cardiovascular disease algorithm - 2020 executive summary","volume":"26","author":"Handelsman","year":"2020","journal-title":"Endocr Pr"},{"key":"10.1016\/j.ajpc.2025.101070_bib0014","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.025581","article-title":"Social determinants of cardiovascular risk, subclinical cardiovascular disease, and cardiovascular events","volume":"12","author":"Acquah","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ajpc.2025.101070_bib0015","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101070_bib0016","article-title":"Peer review committee members, 2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"151","author":"Rao","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2025.101070_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP171764.APPGL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease","volume":"23","author":"Jellinger","year":"2017","journal-title":"Endocr Pr"},{"key":"10.1016\/j.ajpc.2025.101070_bib0018","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.eprac.2024.09.016","article-title":"American Association of Clinical Endocrinology clinical practice guideline on pharmacologic management of adults with dyslipidemia","volume":"31","author":"Patel","year":"2025","journal-title":"Endocr Pr"},{"key":"10.1016\/j.ajpc.2025.101070_bib0019","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1161\/CIRCULATIONAHA.121.056536","article-title":"Cardiovascular benefit of lowering low-density lipoprotein cholesterol below 40 mg\/dL","volume":"144","author":"Marston","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101070_bib0020","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1001\/jamacardio.2018.2258","article-title":"Efficacy and safety of further lowering of low-density lipoprotein cholesterol in patients starting with very low levels: a meta-analysis","volume":"3","author":"Sabatine","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ajpc.2025.101070_bib0021","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/CIRCULATIONAHA.122.063399","article-title":"Association between achieved low-density lipoprotein cholesterol levels and long-term cardiovascular and safety outcomes: an analysis of FOURIER-OLE","volume":"147","author":"Gaba","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101070_bib0022","unstructured":"American Heart Association, Upcoming guideline publication schedule. (https:\/\/professional.heart.org\/en\/guidelines-and-statements\/upcoming-guideline-publication-schedule), 2024. (accessed July 04)."},{"key":"10.1016\/j.ajpc.2025.101070_bib0023","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/CIRCULATIONAHA.119.040151","article-title":"Bridging the gap between cardiology and family medicine","volume":"140","author":"W\u00f3jcik","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101070_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2024.08.013","article-title":"Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: an expert clinical consensus from the national lipid association","volume":"18","author":"Soffer","year":"2024","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2025.101070_bib0025","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1093\/eurheartj\/ehae258","article-title":"Discordance among apoB, non-high-density lipoprotein cholesterol, and triglycerides: implications for cardiovascular prevention","volume":"45","author":"Sniderman","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2025.101070_bib0026","article-title":"Apolipoproteins for cardiovascular risk assessment","volume":"89","author":"Chang","year":"2014","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.ajpc.2025.101070_bib0027","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101070_bib0028","unstructured":"American College of Cardiology, ASCVD risk estimator Plus. (https:\/\/tools.acc.org\/ascvd-risk-estimator-plus\/#!\/calculate\/estimate\/)(accessed February 5, 2024)."},{"key":"10.1016\/j.ajpc.2025.101070_bib0029","unstructured":"American Heart Association, 2018 Prevention guidelines tool CV risk calculator. (https:\/\/static.heart.org\/riskcalc\/app\/index.html#!\/baseline-risk)(accessed February 5, 2024)."},{"key":"10.1016\/j.ajpc.2025.101070_bib0030","unstructured":"American Heart Association, PREVENT\u2122 online calculator. (https:\/\/professional.heart.org\/en\/guidelines-and-statements\/prevent-calculator)(accessed February 5, 2024)."},{"key":"10.1016\/j.ajpc.2025.101070_bib0031","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","article-title":"American Heart Association. Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association","volume":"148","author":"Khan","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101070_bib0032","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and validation of the American Heart Association\u2019s PREVENT equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101070_bib0033","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.38311","article-title":"External validation of the American Heart Association PREVENT cardiovascular disease risk equations","volume":"7","author":"Scheuermann","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajpc.2025.101070_bib0034","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/jamainternmed.2024.1302","article-title":"Atherosclerotic cardiovascular disease risk estimates using the Predicting Risk of Cardiovascular Disease Events equations","volume":"184","author":"Anderson","year":"2024","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ajpc.2025.101070_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.118626","article-title":"Comparison of pooled cohort equation and PREVENT\u2122 risk calculator for statin treatment allocation","volume":"399","author":"Heaton","year":"2024","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2025.101070_bib0036","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(20)32332-1","article-title":"Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials","volume":"396","author":"Gencer","year":"2020","journal-title":"Lancet"},{"article-title":"Department of Health and Human Services USA","year":"2022","series-title":"The heart truth, cholesterol & your heart: what you need to know fact sheet","key":"10.1016\/j.ajpc.2025.101070_bib0037"},{"key":"10.1016\/j.ajpc.2025.101070_bib0038","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/jama.2019.1676","article-title":"Reexamining recommendations for treatment of hypercholesterolemia in older adults","volume":"321","author":"Skolnik","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2025.101070_bib0039","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/CIRCULATIONAHA.120.045851","article-title":"The expected 30-year benefits of early versus delayed primary prevention of cardiovascular disease by lipid lowering","volume":"142","author":"Pencina","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101070_bib0040","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019589","article-title":"Prognostic utility of risk enhancers and coronary artery calcium score recommended in the 2018 ACC\/AHA multisociety cholesterol treatment guidelines over the pooled cohort equation: insights from 3 large prospective cohorts","volume":"10","author":"Akintoye","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ajpc.2025.101070_bib0041","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1001\/jama.2023.11330","article-title":"Screening for lipid disorders in children and adolescents: US Preventive Services Task Force recommendation statement","volume":"330","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2025.101070_bib0042","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0140-6736(23)02182-7","article-title":"Universal paediatric screening for familial hypercholesterolaemia","volume":"403","author":"McGowan","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2025.101070_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2023.100628","article-title":"NLA\/ASPC response to the USPSTF recommendation statement on screening lipid panel in children and adolescents","volume":"17","author":"Goldberg","year":"2024","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.ajpc.2025.101070_bib0044","article-title":"A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice","author":"Koschinsky","year":"202418308","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2025.101070_bib0045","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jcct.2022.07.002","volume":"16","author":"Cury","year":"2022","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.ajpc.2025.101070_bib0046","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1001\/jama.2018.8359","article-title":"Risk assessment for cardiovascular disease with nontraditional risk factors: US Preventive Services Task Force recommendation statement","volume":"320","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2025.101070_bib0047","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1161\/ATV.0000000000000147","volume":"42","author":"Reyes-Soffer","year":"2022","journal-title":"Arter Thromb Vasc Biol"},{"key":"10.1016\/j.ajpc.2025.101070_bib0048","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jama.2012.9624","article-title":"Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals","volume":"308","author":"Yeboah","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2025.101070_bib0049","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1001\/jama.2011.1654","article-title":"Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction","volume":"306","author":"Canto","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2025.101070_bib0050","first-page":"98","article-title":"Major global coronary artery calcium guidelines","volume":"16","author":"Golub Ilana","year":"2023","journal-title":"JACC: Cardiovasc Imaging"},{"key":"10.1016\/j.ajpc.2025.101070_bib0051","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/joim.13176","article-title":"Coronary artery calcium scoring: an evidence-based guide for primary care physicians","volume":"289","author":"Cheong","year":"2021","journal-title":"J Int Med"},{"key":"10.1016\/j.ajpc.2025.101070_bib0052","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/jamacardio.2021.4406","article-title":"Association of age with the diagnostic value of coronary artery calcium score for ruling out coronary stenosis in symptomatic patients","volume":"7","author":"Mortensen","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ajpc.2025.101070_bib0053","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jacl.2020.12.005","article-title":"The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction","volume":"15","author":"Orringer","year":"2021","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2025.101070_bib0054","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.amjcard.2024.03.021","article-title":"Aspirin for primary prevention in patients with elevated coronary artery calcium score: a systematic review of current evidences","volume":"220","author":"Doshi","year":"2024","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ajpc.2025.101070_bib0055","first-page":"1181","article-title":"When does a calcium score equate to secondary prevention?: insights from the multinational CONFIRM registry","volume":"16","author":"Budoff","year":"2023","journal-title":"JACC: Cardiovasc Imaging"},{"key":"10.1016\/j.ajpc.2025.101070_bib0056","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/jamacardio.2021.1810","article-title":"Use of lipid-lowering therapies over 2 years in GOULD, a registry of patients with atherosclerotic cardiovascular disease in the US","volume":"6","author":"Cannon","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ajpc.2025.101070_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2024.03.382","article-title":"An \"inclisiran first\" strategy vs usual care in patients with atherosclerotic cardiovascular disease","author":"Koren","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2025.101070_bib0058","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/clc.23935","article-title":"Nonadherence to lipid-lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease","volume":"46","author":"Desai","year":"2023","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ajpc.2025.101070_bib0059","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1080\/00325481.2022.2117498","article-title":"LDL-C target attainment in secondary prevention of ASCVD in the United States: barriers, consequences of nonachievement, and strategies to reach goals","volume":"134","author":"Underberg","year":"2022","journal-title":"Postgr Med"},{"key":"10.1016\/j.ajpc.2025.101070_bib0060","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1056\/NEJMoa1800389","article-title":"Primary prevention of cardiovascular disease with a mediterranean diet supplemented with extra-virgin olive oil or nuts","volume":"378","author":"Estruch","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2025.101070_bib0061","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.advnut.2023.01.005","article-title":"Soluble fiber supplementation and serum lipid profile: a systematic review and dose-response meta-analysis of randomized controlled trials","volume":"14","author":"Ghavami","year":"2023","journal-title":"Adv Nutr"},{"key":"10.1016\/j.ajpc.2025.101070_bib0062","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/CIRCULATIONAHA.110.010710","article-title":"Dose response between physical activity and risk of coronary heart disease: a meta-analysis","volume":"124","author":"Sattelmair","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101070_bib0063","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/S0140-6736(16)30370-1","article-title":"Does physical activity attenuate, or even eliminate, the detrimental association of sitting time with mortality? A harmonised meta-analysis of data from more than 1 million men and women","volume":"388","author":"Ekelund","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2025.101070_bib0064","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/HYPERTENSIONAHA.112.193268","article-title":"Insomnia with objective short sleep duration and incident hypertension: the Penn State Cohort","volume":"60","author":"Fernandez-Mendoza","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.ajpc.2025.101070_bib0065","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1037\/hea0000228","article-title":"Positive psychological health and stroke risk: the benefits of emotional vitality","volume":"34","author":"Lambiase","year":"2015","journal-title":"Health Psychol"},{"key":"10.1016\/j.ajpc.2025.101070_bib0066","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1161\/CIRCHEARTFAILURE.113.000644","article-title":"Prospective study of the association between dispositional optimism and incident heart failure","volume":"7","author":"Kim","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ajpc.2025.101070_bib0067","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1161\/CIRCULATIONAHA.115.017926","article-title":"Relation of smoking with total mortality and cardiovascular events among patients with diabetes mellitus: a meta-analysis and systematic review","volume":"132","author":"Pan","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101070_bib0068","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1093\/eurheartj\/ehy182","article-title":"Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract","volume":"39","author":"Mach","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2025.101070_bib0069","doi-asserted-by":"crossref","first-page":"n135","DOI":"10.1136\/bmj.n135","article-title":"Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials","volume":"372","author":"Herrett","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ajpc.2025.101070_bib0070","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jacl.2022.09.001","article-title":"Assessment and management of statin-associated muscle symptoms (SAMS): a clinical perspective from the National Lipid Association","volume":"17","author":"Warden","year":"2023","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2025.101070_bib0071","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJMoa2215024","article-title":"Bempedoic acid and cardiovascular outcomes in statin-intolerant patients","volume":"388","author":"Nissen","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2025.101070_bib0072","unstructured":"US Food and Drug Administration, FDA requests removal of strongest warning against using cholesterol-lowering statins during pregnancy; still advises most pregnant patients should stop taking statins. (https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-requests-removal-strongest-warning-against-using-cholesterol-lowering-statins-during-pregnancy), 2021. (accessed January 30, 2024)."},{"key":"10.1016\/j.ajpc.2025.101070_bib0073","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s40119-020-00170-x","article-title":"Prevalence of US adults with triglycerides\u2009\u2265\u2009150 mg\/dl: NHANES 2007-2014","volume":"9","author":"Fan","year":"2020","journal-title":"Cardiol Ther"},{"key":"10.1016\/j.ajpc.2025.101070_bib0074","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jacc.2021.06.011","article-title":"2021 ACC Expert Consensus Decision Pathway on the management of ASCVD risk reduction in patients with persistent hypertriglyceridemia: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"78","author":"Virani","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2025.101070_bib0075","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1038\/s41467-024-46686-x","article-title":"Elevated blood remnant cholesterol and triglycerides are causally related to the risks of cardiometabolic multimorbidity","volume":"15","author":"Zhao","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpc.2025.101070_bib0076","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.amjcard.2016.04.004","article-title":"Triglycerides and triglyceride-rich lipoproteins in the causal pathway of cardiovascular disease","volume":"118","author":"Budoff","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ajpc.2025.101070_bib0077","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/eurjpc\/zwad331","article-title":"The effect of fibrates on lowering low-density lipoprotein cholesterol and cardiovascular risk reduction: a systemic review and meta-analysis","volume":"31","author":"Kim","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ajpc.2025.101070_bib0078","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2025.101070_bib0079","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(07)60527-3","article-title":"Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis","volume":"369","author":"Yokoyama","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2025.101070_bib0080","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1001\/jama.2020.22258","article-title":"Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: the STRENGTH randomized clinical trial","volume":"324","author":"Nicholls","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2025.101070_bib0081","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jacl.2025.03.013","article-title":"Familial chylomicronemia syndrome: an expert clinical review from the National Lipid Association","volume":"19","author":"Javed","year":"2025","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2025.101070_bib0082","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/CIRCULATIONAHA.118.039107","article-title":"Inhibition of angiopoietin-like protein 3 with a monoclonal antibody reduces triglycerides in hypertriglyceridemia","volume":"140","author":"Ahmad","year":"2019","journal-title":"Circulation"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266666772500145X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266666772500145X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T21:00:29Z","timestamp":1760648429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266666772500145X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":82,"alternative-id":["S266666772500145X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2025.101070","relation":{},"ISSN":["2666-6677"],"issn-type":[{"type":"print","value":"2666-6677"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Demystifying the nuances of the lipid patient: a guide for primary care providers","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2025.101070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101070"}}